Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880)

Price and availability

119 944 ₸

Availability

Order now and get it on Thursday February 25, 2021

Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

You may also be interested in

FirePlex Cytometer Run Buffer 1 (ab245836)
Product image
Mouse SCF ELISA Kit (ab100740)
Product image
Anti-ATG7 antibody [EPR6251] - BSA and Azide free (ab232348)
Product image
Alexa Fluor® 647 Anti-CaMKII antibody [EP1829Y] (ab196165)

Overview

  • Product name

    Hela-DFO treated (0.5mM, 24h) Nuclear Lysate
  • General notes

    We recommend aliquoting the extracts into single use fractions and then storing them at -80°C.


    The cells were treated for 24 hours with a 0.5mM solution of Deferoxamine (DFO). DFO is used as a hypoxia-mimetic agent to stabilize Hypoxia Inducible Factor 1 (HIF-1). DFO stabilizes HIF-1 through the inhibition of Prolyl Hydroxylases (PHDs) which target HIF-1 through degradation. The mechanism of DFO inhibition is likely through the chelation of Fe2+ bound to the active site of PHD which is required for enzymatic activity.

Properties

  • Mycoplasma free

    Yes
  • Form

    Liquid
  • Storage instructions

    Shipped on Dry Ice. Upon delivery aliquot. Store at -80°C. Avoid freeze / thaw cycle.
  • Storage buffer

    Constituent: 10% DTT
  • Concentration information loading...
  • Lysate notes

    The cells were treated for 24 hours with a 0.5mM solution of Deferoxamine (DFO). DFO is used as a hypoxia-mimetic agent to stabilize Hypoxia Inducible Factor 1 (HIF-1). DFO stabilizes HIF-1 through the inhibition of Prolyl Hydroxylases (PHDs) which target HIF-1 through degradation. The mechanism of DFO inhibition is likely through the chelation of Fe2+ bound to the active site of PHD which is required for enzymatic activity.
  • Background

    HeLa cells are human epithelial cells from a fatal cervical carcinoma. The cell line was derived from cervical cancer cells taken from Henrietta Lacks, in 1951. Horizontal gene transfer from human papillomavirus 18 (HPV18) to human cervical cells created the HeLa genome which is different from either parent genome in various ways including its number of chromosomes. HeLa cells have a modal chromosome number of 82, with 4 copies of chromosome 12 and 3 copies of chromosomes 6, 8, and 17. HeLa cells are adherent cells (they stick to surfaces) and maintain contact inhibition in vitro.

Images

  • Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880)
    Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880)
    All lanes : Simply Blue Coomassie Stain 20ml

    Lane 1 : HeLa nuclear extract lysate (ab150036)
    Lane 2 : Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880)

    Lysates/proteins at 10 µg per lane.
  • Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880)
    Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880)
    All lanes : Anti-HIF-1 alpha antibody [H1alpha67] (ab1) at 5 µg/ml

    Lane 1 : HeLa whole cell lysate (ab150035)
    Lane 2 : Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880)

    Lysates/proteins at 40 µg per lane.

    Secondary
    All lanes : Goat Anti-Mouse IgG H&L (HRP) preadsorbed (ab97040) at 1/10000 dilution
  • Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880)
    Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880)
    All lanes : Anti-HIF-1 alpha antibody [EP1215Y] (ab51608) at 1/2000 dilution

    Lane 1 : HeLa nuclear extract lysate (ab150036)
    Lane 2 : Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880)

    Lysates/proteins at 40 µg per lane.

    Secondary
    All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/10000 dilution

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-GART antibody [EPR11622] - BSA and Azide free (ab249500)

  •  
  • Product image

    Anti-TNF alpha antibody [EPR21753-109] - BSA and Azide free (ab252382)

  •  
  • Product image

    Anti-ITPA antibody [EPR8779] - BSA and Azide free (ab248981)

  •  
  • Goat Anti-Human IgG H&L (HRP) (ab81202)

  •  
  • Product image

    Anti-CD8 alpha antibody [SP239] - BSA and Azide free (ab236230)

  •  
  • Product image

    Anti-TIMMDC1/C3orf1 antibody [EPR11808] - BSA and Azide free (ab249668)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.